Keurig Dr Pepper reports strong Q3 2025 results, driven by volume growth, pricing actions, and the GHOST acquisition.
Researchers uncover genetic evidence of paratyphoid fever and relapsing fever in 1812 French soldiers, challenging the long-held view that typhus alone accounted for the Grande Armée's toll.
Keurig Dr Pepper reports strong Q3 2025 results, driven by volume growth, pricing actions, and the GHOST acquisition.
Researchers uncover genetic evidence of paratyphoid fever and relapsing fever in 1812 French soldiers, challenging the long-held view that typhus alone accounted for the Grande Armée's toll.